RNA exosome mutations in pontocerebellar hypoplasia alter ribosome biogenesis and p53 levels
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The RNA exosome is a ubiquitously expressed complex of nine core proteins (EXOSC1-9) and associated nucleases responsible for RNA processing and degradation. Mutations in EXOSC3,EXOSC8,EXOSC9, and the exosome cofactor RBM7 cause pontocerebellar hypoplasia and motor neuronopathy. We investigated the consequences of exosome mutations on RNA metabolism and cellular survival in zebrafish and human cell models. We observed that levels of mRNAs encoding p53 and ribosome biogenesis factors are increased in zebrafish lines with homozygous mutations of exosc8 or exosc9, respectively. Consistent with higher p53 levels, mutant zebrafish have a reduced head size, smaller brain, and cerebellum caused by an increased number of apoptotic cells during development. Down-regulation of EXOSC8 and EXOSC9 in human cells leads to p53 protein stabilisation and G2/M cell cycle arrest. Increased p53 transcript levels were also observed in muscle samples from patients with EXOSC9 mutations. Our work provides explanation for the pathogenesis of exosome-related disorders and highlights the link between exosome function, ribosome biogenesis, and p53-dependent signalling. We suggest that exosome-related disorders could be classified as ribosomopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Failure of the exosome (and therefore ribosome biogenesis) leads to activation of the nucleolar stress response, characterized by upregulation of cell-cycle regulators, cell-cycle arrest, and apoptosis.11”
From Biallelic pathogenic variants in EXOSC3 mediate thrombotic microangiopathy of the kidney (2026) · cites this paper as [11]
In the citing paper
“At the molecular level, homozygous exosc8 and exosc9 crispants exhibit upregulation of p53 responsive and ribosome biogenesis transcripts, G2/M cell-cycle arrest, and excess of apoptosis in the developing brain, leading to decreased cerebellar and head size [194].”
From The RNA exosome: mechanisms of RNA surveillance, regulation, and disease (2026) · cites this paper as [194]
In the citing paper
“Other variants, specifically G31A and W238R, have been extensively studied in yeast and flies, and in one case, G31A has been studied in induced neural progenitor cells from patient fibroblasts (38,40–42).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo
Moreno-Mateos, M. A., Vejnar, C. E., Beaudoin, J.-D., Fernandez, J. P., Mis, E. K., Khokha, M. K., & Giraldez, A. J. (2015) · Nature Methods · doi:10.1038/nmeth.3543 · Cited by 1,290 · cited 1×
“Crisprscan (Moreno-Mateos et al, 2015) was used to identify a target site in exon 2 of exosc8 and exon 3 of exosc9 in zebra fi sh. sgRNA was produced as described elsewhere (Varshney et al, 2015).”
RNA Exosome-Regulated Long Non-Coding RNA Transcription Controls Super-Enhancer Activity
Pefanis, E., Wang, J., Rothschild, G., Lim, J., Kazadi, D., Sun, J., Federation, A., Chao, J., Elliott, O., Liu, Z.-P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.034 · Cited by 464 · cited 1×
“…cell lines had profound consequences on the levels of many different RNA types: Ablation of EXOSC3 and EXOSC10 in mouse embryonic stem (ES) cells (Pefanis et al, 2015) resulted in increased levels of long non-coding RNAs, antisense RNAs, and enhancer RNAs compared with wild-type control ES cell…”
Meyer, K., Ferraiuolo, L., Miranda, C. J., Likhite, S., McElroy, S., Renusch, S., Ditsworth, D., Lagier-Tourenne, C., Smith, R. A., Ravits, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314085111 · Cited by 361
Wan, J., Yourshaw, M., Mamsa, H., Rudnik-Schöneborn, S., Menezes, M. P., Hong, J. E., Leong, D. W., Senderek, J., Salman, M. S., Chitayat, D., et al. (2012) · Nature Genetics · doi:10.1038/ng.2254 · Cited by 257 · cited 3×
“This phenotype was consistent with what was previously seen with morpholino oligos targeting exosc3 , exosc8 , and exosc9 (Wan et al, 2012; Boczonadi et al, 2014; Burns et al, 2018).”
Transcriptome-wide Analysis of Exosome Targets
Schneider, C., Kudla, G., Wlotzka, W., Tuck, A., & Tollervey, D. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.013 · Cited by 195
Self-citationBoczonadi, V., Müller, J. S., Pyle, A., Munkley, J., Dor, T., Quartararo, J., Ferrero, I., Karcagi, V., Giunta, M., Polvikoski, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms5287 · Cited by 149 · cited 9×
“We have previously shown that exosc8 morphant zebra fi sh and patients with EXOSC8 mutations had myelination defects (Boczonadi et al, 2014), which might also relate to a perturbation of ribosome biogenesis.”
InfluentialSelf-citationBurns, D. T., Donkervoort, S., Müller, J. S., Knierim, E., Bharucha-Goebel, D., Faqeih, E. A., Bell, S. K., AlFaifi, A. Y., Monies, D., Millan, F., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.03.011 · Cited by 88
Self-citationSchwabova, J., Brozkova, D. S., Petrak, B., Mojzisova, M., Pavlickova, K., Haberlova, J., Mrazkova, L., Hedvicakova, P., Hornofova, L., Kaluzova, M., et al. (2013) · Journal of Neurogenetics · doi:10.3109/01677063.2013.814651 · Cited by 44 · cited 1×
“The patient with EXOSC3 mutations suffered from a severe form of PCH type 1 that included severe hypotonia, weakness, absent motor and mental development, and signs of neuronal loss in spinal anterior horns, cerebellum, and parts of the midbrain (Schwabova et al, 2013).”
Gillespie, A., Gabunilas, J., Jen, J. C., & Chanfreau, G. F. (2017) · RNA · doi:10.1261/rna.060004.116 · Cited by 35 · cited 3×
“…pro fi les in fi broblasts from patients with mutations in EXOSC8 , EXOSC9 , and the exosome cofactor RBM7 , as well as in zebra fi sh where the expression of these genes was down-regulated via the injection of antisense morpholinos (Boczonadi et al, 2014; Giunta et al, 2016; Burns et al, 2018).”
Yang, X., Bayat, V., DiDonato, N., Zhao, Y., Zarnegar, B., Siprashvili, Z., Lopez-Pajares, V., Sun, T., Tao, S., Li, C., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddz251 · Cited by 31
Research works printed but not linked: 74
- 10.1093/emboj/18.19.5399 · DOI · Paper page
- 10.1093/bioinformatics/btu638 · DOI · Paper page
- Anderson, 2002, Chordin and noggin promote organizing centers of forebrain development in the mouse, Development, 129, 4975, 10.1242/dev.129.21.4975 · DOI · Paper page
- Ang, 1994, Positive and negative signals from mesoderm regulate the expression of mouse Otx2 in ectoderm explants, Development, 120, 2979, 10.1242/dev.120.10.2979 · DOI · Paper page
- 10.1016/j.bbacli.2014.05.002 · DOI
- 10.1016/j.ajhg.2009.04.017 · DOI
- 10.3390/biom8040123 · DOI · Paper page
- 10.1083/jcb.201811148 · DOI · Paper page
- 10.1016/j.ejmg.2019.01.012 · DOI · Paper page
- 10.1016/j.cell.2009.08.042 · DOI · Paper page
- 10.1016/S0092-8674(00)00065-9 · DOI · Paper page
- 10.1016/j.ajhg.2016.08.009 · DOI
- 10.1038/ng.204 · DOI · Paper page
- 10.1038/nature25449 · DOI · Paper page
- 10.1136/jmedgenet-2012-100892 · DOI
- 10.1111/febs.14622 · DOI
- 10.1016/j.celrep.2019.02.012 · DOI · Paper page
- 10.1136/jmedgenet-2015-103511 · DOI · Paper page
- 10.1093/bioinformatics/bts635 · DOI · Paper page
- 10.1016/S1046-2023(02)00023-3 · DOI · Paper page
- 10.1021/acschembio.8b00745 · DOI
- 10.1101/gad.189951.112 · DOI · Paper page
- 10.1093/hmg/ddw149 · DOI · Paper page
- 10.1016/j.molcel.2012.08.018 · DOI · Paper page
- 10.1523/JNEUROSCI.1030-08.2008 · DOI · Paper page
- 10.1016/j.ejpn.2018.03.011 · DOI · Paper page
- 10.1101/gad.1183804 · DOI · Paper page
- 10.1016/j.cell.2014.02.058 · DOI · Paper page
- 10.1093/hmg/ddr034 · DOI
- 10.1002/aja.1002030302 · DOI · Paper page
- 10.1261/rna.066589.118 · DOI
- 10.1016/j.devcel.2014.11.018 · DOI · Paper page
- 10.1016/j.mod.2011.11.001 · DOI
- 10.1038/ng.3762 · DOI · Paper page
- 10.1523/JNEUROSCI.5584-11.2012 · DOI · Paper page
- 10.1074/jbc.M208338200 · DOI
- 10.1016/j.cell.2006.10.037 · DOI · Paper page
- 10.1016/j.celrep.2014.12.026 · DOI · Paper page
- 10.1016/j.molcel.2011.06.028 · DOI · Paper page
- 10.1101/gad.9.21.2646 · DOI · Paper page
- 10.2144/000112619 · DOI · Paper page
- 10.1080/15476286.2016.1249091 · DOI
- 10.1016/S0092-8674(00)80432-8 · DOI · Paper page
- 10.1261/rna.064626.117 · DOI · Paper page
- 10.1093/emboj/21.1.165 · DOI · Paper page
- 10.3233/JND-150086 · DOI
- 10.1371/journal.pgen.1006187 · DOI
- 10.1042/BST20160106 · DOI
- 10.3389/fphys.2014.00026 · DOI
- 10.1038/nature14580 · DOI · Paper page
- 10.1261/rna.033779.112 · DOI · Paper page
- 10.1016/j.cell.2014.03.049 · DOI · Paper page
- 10.1038/nmeth.2089 · DOI · Paper page
- 10.1016/j.tibs.2013.06.013 · DOI · Paper page
- 10.1038/358687a0 · DOI · Paper page
- 10.1371/journal.pone.0032317 · DOI
- 10.1261/rna.043471.113 · DOI · Paper page
- 10.1016/j.celrep.2013.08.049 · DOI · Paper page
- 10.1083/jcb.201207131 · DOI · Paper page
- 10.1042/BST20120061 · DOI · Paper page
- 10.1038/emboj.2010.122 · DOI · Paper page
- 10.1016/j.devcel.2014.12.012 · DOI
- 10.1101/gr.189597.115 · DOI · Paper page
- 10.1016/j.molcel.2013.08.011 · DOI · Paper page
- 10.1038/emboj.2010.121 · DOI · Paper page
- 10.1002/1873-3468.12682 · DOI
- 10.1016/j.cell.2010.04.035 · DOI · Paper page
- 10.1128/MCB.20.2.441-452.2000 · DOI · Paper page
- 10.1101/gr.186379.114 · DOI · Paper page
- 10.1007/s12311-011-0323-9 · DOI
- 10.1002/wrna.117 · DOI · Paper page
- 10.1016/j.cell.2005.04.030 · DOI · Paper page
- 10.15698/cst2018.06.139 · DOI · Paper page
- 10.1371/journal.pgen.1004074 · DOI
Cited by
Bi‐allelic missense variant, p. Ser35Leu in EXOSC1 is associated with pontocerebellar hypoplasia
Somashekar, P. H., Kaur, P., Stephen, J., Guleria, V. S., Kadavigere, R., Girisha, K. M., Bielas, S., Upadhyai, P., & Shukla, A. (2021) · Clinical Genetics · doi:10.1111/cge.13928 · Cited by 32
“Previously, missense variants in different exosome subunits were shown to significantly reduce the amount of protein.(9,10,17) Each subunit of the complex is critical for its assembly and defects in any one subunit might affect the complex formation.”
BackgroundFasken, M. B., Leung, S. W., Cureton, L. A., Al-Awadi, M., Al-Kindy, A., van Hoof, A., Khoshnevis, S., Ghalei, H., Al-Maawali, A., & Corbett, A. H. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107571 · Cited by 20
Cavusoglu, D., Ozturk, G., Turkdogan, D., Kurul, S. H., Yis, U., Komur, M., Incecik, F., Kara, B., Sahin, T., Unver, O., et al. (2024) · The Cerebellum · doi:10.1007/s12311-024-01690-1 · Cited by 8
“The substantial task of the exome includes processing of mRNA, rRNA and probably tRNA of RNA precursor, transcript and unspliced degradation, and regulation of RNA processing in cerebellar and spinal neurons [9, 23–25].”
BackgroundRunnebohm, A. M., Wijeratne, H. R. S., Barron, M. P., Smith-Kinnaman, W. R., Rooney, J. D., Peck Justice, S. A., Cureton, L. A., Holland, A., Ghalei, H., Pelletier, S., et al. (2025) · doi:10.1101/2025.05.31.657176 · Cited by 4
The RNA exosome: mechanisms of RNA surveillance, regulation, and disease
Upadhyai, P., Quadri, N., & Chandran, D. (2026) · RNA Biology · doi:10.1080/15476286.2026.2685379 · Cited by 2
Metadata
- Authors
- Müller, J. S., Burns, D. T., Griffin, H., Wells, G. R., Zendah, R. A., Munro, B., Schneider, C., & Horvath, R.
- Affiliations
- Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
- Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK
- Venue
- Life Science Alliance
- Publisher
- Life Science Alliance, LLC
- Published
- 2020-06-11
- Volume
- 3
- Issue
- 8
- Pages
- e202000678
- ISSN
- 2575-1077
- Cited by
- 30
- References
- 11
- Language
- en
- Funders
- Medical Research Council (MR/N025431/1)
- Wellcome Investigator Award (109915/Z/15/Z)
- The Newton Fund (MR/N027302/1)
- The Wellcome Centre for Mitochondrial Research (203105/Z/16/Z)
- Royal Society (UF150691)
- Biotechnology and Biological Sciences Research Council/Medical Research Council (BB/R00143X/1)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.